ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 69 filers reported holding ALIGOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,368,000 | – | 214,254 | – | 1.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $2,808,000 | 4.30% |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $899,000 | 0.45% |
| Vivo Capital, LLC | 3,547,030 | $4,292,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,547,710 | $1,873,000 | 0.28% |
| Newtyn Management, LLC | 962,088 | $1,164,000 | 0.22% |
| EcoR1 Capital, LLC | 3,948,360 | $4,778,000 | 0.16% |
| Boxer Capital, LLC | 1,526,048 | $1,847,000 | 0.12% |
| Novo Holdings A/S | 1,950,000 | $2,360,000 | 0.12% |
| HHLR ADVISORS, LTD. | 2,365,064 | $2,862,000 | 0.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 58,392 | $71,000 | 0.02% |